Yonsei University Switches On IBM's 120-Qubit Nighthawk r2 in Songdo on 4 November 2026: What Its Drug-Discovery Time Targets Rest On
How Yonsei plans quantum drug discovery on IBM Quantum Nighthawk r2 in Songdo
Quentir Medicine Monitor
Evidence-based insights for quantum medicine.
Yonsei University put a new processor into its IBM quantum computer at the Songdo International Campus in Incheon and showed it to the press on 4 November 2026. The machine now runs on IBM Quantum Nighthawk r2, and the university says it will use the system to cut years from the early, computational stages of drug development.
The time targets came from Chung Jae-ho, head of Yonsei's quantum initiative, at a media briefing in Songdo. As Digital Daily reported on 4 November, he described algorithms that would shorten the target protein search from one to two years to five months, and the search for a compound and its optimization into a drug candidate from four years to two. The Seoul Economic Daily account of the same day presents both figures as goals of a pipeline that combines quantum algorithms with artificial intelligence, and quotes Chung expecting a speed gain of 40 to 50 percent over AI algorithms that industry uses as standard.
For a hospital or pharmaceutical reader, the useful part of the briefing is how carefully Chung drew the boundary of quantum drug discovery. He put the usual length of drug development at about 15 years and said that the last seven to eight, the clinical trials, are not something faster computation can shorten. Yonsei's work concentrates on the stages before any patient is involved: finding the protein that drives a disease and finding a molecule that acts on it.
Yonsei installed Korea's first IBM Quantum System One in 2024, built around a 127-qubit Eagle processor. Chung called the two years since then "season 1" and the upgrade "season 2." According to Seoul Economic Daily, this is the first Nighthawk processor installed in an outside institution's own facility.
IBM introduced the design in its announcement of 12 November 2025: 120 qubits linked by 218 tunable couplers, each qubit connected to up to four nearest neighbors in a square lattice, with circuits of up to 5,000 two-qubit gates at launch. On the Eagle chip each qubit reaches two or three neighbors. Better connectivity matters because qubits that are not directly linked need extra operations to exchange information, and every extra operation adds error.
Yonsei describes the chip as having 458 physical qubits. Digital Daily explains the count: 120 programmable qubits that run circuits, 218 couplers and 120 reset elements. The 120 computing qubits are physical qubits without error correction, so they are a different unit from the logical qubits that a fault-tolerant machine would use. IBM plans to expand beyond 500 programmable qubits, connect several processors past 1,000 qubits, and build a large error-corrected computer by 2029.
Dong-A University Opens Its G-LAMP Atomic and Quantum Research Center in Busan on 20 October 2026: KRW 25 Billion for Quantum Computing, Medical Image Analysis and Radioisotope Drugs
What Dong-A University opened in Busan on 20 October 2026
Quentir Medicine Monitor
Evidence-based insights for quantum medicine.
Dong-A University in Busan opened the offices of its new G-LAMP research group on 20 October 2026, with about 100 guests on its Seunghak Campus. The group has roughly KRW 25 billion in national funding to build a research platform on atomic and quantum technology that reaches from basic science into diagnosis and treatment.
The university announced the opening on 21 October, and Korean outlets including Money Today reported it the same day. G-LAMP is a basic science research hub program run by Korea's Ministry of Education and the National Research Foundation of Korea. Dong-A was selected as a new group in 2025, and the October ceremony marks the start of its full research activity. President Lee Hae-woo, project director Jeong Jin-woong, Busan's deputy mayor for administration Kim Kyung-deok and Heo Jeong-eun of the National Research Foundation were among those present.
The research plan, as the university describes it, has a clear medical end. Its listed priorities include quantum computing and information processing applied to medical image analysis, the synthesis of new quantum materials, research using radioisotopes, and the development of diagnostic and therapeutic substances with clinical application. Jeong said the group would build an integrated platform covering everything from basic technology to clinical application, and Lee spoke of combining atomic and quantum science with advanced medical technology to open a new field.
For a reader in a hospital or a pharmaceutical company, the opening is an early signal. It funds people, laboratories and a direction of work in Korea's southeast. The reports of the opening cite no study, no device, no measured outcome and no timetable for clinical work. What it does show is where a Korean university chose to point about KRW 25 billion of public money for quantum research: toward imaging, radiopharmaceuticals and the clinic.
The reports also leave some details uneven. The venue is given as the arts and sports college hall in some accounts and as the natural sciences college lobby in others, and the length of the funding period is reported in two ways. The substance of the plan is the same in every account. The differences matter for anyone who cites the program in a funding comparison.
IonQ Will Supply SDT a Superion 256 Quantum Computer, Announced 21 September 2026, and a Korean Report Places It in a Cancer Center's Hybrid Data Center, With Deliveries From 2027
Quentir Medicine Monitor
Evidence-based insights for quantum medicine.
On 21 September 2026 the American quantum company IonQ and the Korean system integrator SDT announced a multi-year partnership under which IonQ will supply SDT with its newest quantum computer and a quantum memory module. The Korean newspaper Digital Times reported on 22 September, citing SDT, that the computer is meant for the hybrid data center of a cancer center in South Korea. For a hospital that buys imaging systems, sequencers and compute clusters on multi-year cycles, the announcement raises a practical question about what this machine can do for oncology.
The answer depends on dates and on the precise wording of two press accounts. IonQ will supply a Superion 256, a trapped-ion machine the company announced on 8 September 2026 and says it will begin delivering to customers in 2027. The cancer center has not been identified, and SDT says the project details will be disclosed later. What exists today is a purchase agreement, a plan for a hybrid quantum-classical data center, and a planned manufacturing site in the city of Gumi. The cited announcements report no medical workload or results.
That makes this a procurement story at an early stage, and procurement stories are where hospital leaders, research directors and health ministries decide whether to wait, pilot or budget. This Monitor sets out what each party said, what the machine is, and which questions a cancer center would need answered before the system becomes clinical research infrastructure.
The Korean detail matters because the English release and the Korean report differ in one respect that a buyer should notice. The difference concerns where the computer goes.